For research purposes only. Not for human consumption. For use by licensed researchers only.
Sermorelin (GHRH 1-29) is a synthetic analogue of endogenous growth hormone-releasing hormone (GHRH), representing the first 29 amino acids of the 44-amino acid native peptide. It is the shortest fully active fragment of GHRH known to stimulate physiological GH secretion from the anterior pituitary.
Mechanism of Action
Sermorelin binds to GHRH receptors on somatotrophs in the anterior pituitary, stimulating the production and release of endogenous growth hormone through physiological feedback mechanisms. Unlike direct GH administration, Sermorelin preserves the natural pulsatile pattern and hypothalamic-pituitary axis regulation.
Research Applications
- Growth hormone axis regulation research
- Pituitary somatotroph function studies
- Sleep quality and slow-wave sleep modulation research
- IGF-1 stimulation and downstream signaling models
- Growth hormone deficiency and anti-aging models
Research Grade Peptide
| Compound | Sermorelin (GHRH 1-29 Fragment) |
| Strength | 10 mg |
| Vial Size | 3 mL |
| Vial Color | Clear |
| Form | Lyophilized Powder |
| Purity | >98% (HPLC verified) |
| Price | $95.00 |
This compound is provided strictly for in vitro and laboratory research. It has not been evaluated by the FDA and is not intended for diagnostic, therapeutic, or human use. Available to licensed researchers only.